145 related articles for article (PubMed ID: 38442518)
1. Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations.
Gool JK; Zhang Z; Fronczek R; Amesz P; Khatami R; Lammers GJ
Sleep Med; 2024 Apr; 116():105-114. PubMed ID: 38442518
[TBL] [Abstract][Full Text] [Related]
2. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis.
Zhang Y; Ren R; Yang L; Zhang H; Shi Y; Vitiello MV; Tang X; Sanford LD
Sleep Med Rev; 2022 Jun; 63():101610. PubMed ID: 35278894
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of central disorders of hypersomnolence with manual and artificial-intelligence-derived polysomnographic measures.
Cesari M; Egger K; Stefani A; Bergmann M; Ibrahim A; Brandauer E; Högl B; Heidbreder A
Sleep; 2023 Feb; 46(2):. PubMed ID: 36455881
[TBL] [Abstract][Full Text] [Related]
4. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study.
Barateau L; Jaussent I; Lopez R; Boutrel B; Leu-Semenescu S; Arnulf I; Dauvilliers Y
Sleep; 2016 Mar; 39(3):573-80. PubMed ID: 26564129
[TBL] [Abstract][Full Text] [Related]
5. Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias.
Leu-Semenescu S; Maranci JB; Lopez R; Drouot X; Dodet P; Gales A; Groos E; Barateau L; Franco P; Lecendreux M; Dauvilliers Y; Arnulf I
J Clin Sleep Med; 2022 May; 18(5):1355-1364. PubMed ID: 34984974
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia.
Wang P; Li Q; Dong X; An H; Li J; Zhao L; Yan H; Aritake K; Huang Z; Strohl KP; Urade Y; Zhang J; Han F
Sleep; 2021 Apr; 44(4):. PubMed ID: 33175978
[TBL] [Abstract][Full Text] [Related]
7. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.
Lopez R; Doukkali A; Barateau L; Evangelista E; Chenini S; Jaussent I; Dauvilliers Y
Sleep; 2017 Dec; 40(12):. PubMed ID: 29099966
[TBL] [Abstract][Full Text] [Related]
8. Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
Buonocore SM; van der Most RG
Front Immunol; 2022; 13():902840. PubMed ID: 36311717
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence.
Barateau L; Jaussent I; Roeser J; Ciardiello C; Kilduff TS; Dauvilliers Y
Sleep; 2021 Jul; 44(7):. PubMed ID: 33476396
[TBL] [Abstract][Full Text] [Related]
10. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.
Maski KP; Colclasure A; Little E; Steinhart E; Scammell TE; Navidi W; Diniz Behn C
Sleep; 2021 Jul; 44(7):. PubMed ID: 33512510
[TBL] [Abstract][Full Text] [Related]
11. Genetics and epigenetics of rare hypersomnia.
Mogavero MP; DelRosso LM; Bruni O; Salemi M; Salsone M; Novellino F; Zucconi M; Ferini Strambi L; Ferri R
Trends Genet; 2023 May; 39(5):415-429. PubMed ID: 36842900
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity between central disorders of hypersomnolence and immune-based disorders.
Barateau L; Lopez R; Arnulf I; Lecendreux M; Franco P; Drouot X; Leu-Semenescu S; Jaussent I; Dauvilliers Y
Neurology; 2017 Jan; 88(1):93-100. PubMed ID: 27864522
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study.
Wasling HB; Bornstein A; Wasling P
Sleep Med; 2020 Dec; 76():104-112. PubMed ID: 33152582
[TBL] [Abstract][Full Text] [Related]
14. On-the-road driving performance of patients with central disorders of hypersomnolence.
van der Sluiszen NNJJM; Urbanus B; Lammers GJ; Overeem S; Ramaekers JG; Vermeeren A
Traffic Inj Prev; 2021; 22(2):120-126. PubMed ID: 33543997
[TBL] [Abstract][Full Text] [Related]
15. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia.
Nigam M; Hippolyte A; Dodet P; Gales A; Maranci JB; Al-Youssef S; Leu-Semenescu S; Arnulf I
J Clin Sleep Med; 2022 Jan; 18(1):255-263. PubMed ID: 34314345
[TBL] [Abstract][Full Text] [Related]
16. Metabolic-Syndrome-Related Comorbidities in Narcolepsy Spectrum Disorders: A Preliminary Cross-Sectional Study in Japan.
Futenma K; Takaesu Y; Nakamura M; Hayashida K; Takeuchi N; Inoue Y
Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627822
[TBL] [Abstract][Full Text] [Related]
17. Multiple sleep latency test and polysomnography in patients with central disorders of hypersomnolence.
Dietmann A; Gallino C; Wenz E; Mathis J; Bassetti CLA
Sleep Med; 2021 Mar; 79():6-10. PubMed ID: 33453460
[TBL] [Abstract][Full Text] [Related]
18. Decreased sleep stage transition pattern complexity in narcolepsy type 1.
Ferri R; Pizza F; Vandi S; Iloti M; Plazzi G
Clin Neurophysiol; 2016 Aug; 127(8):2812-2819. PubMed ID: 27417057
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction in central disorders of hypersomnolence: A systematic review.
Filardi M; D'Anselmo A; Agnoli S; Rubaltelli E; Mastria S; Mangiaruga A; Franceschini C; Pizza F; Corazza GE; Plazzi G
Sleep Med Rev; 2021 Oct; 59():101510. PubMed ID: 34166991
[TBL] [Abstract][Full Text] [Related]
20. French consensus. Management of patients with hypersomnia: Which strategy?
Lopez R; Arnulf I; Drouot X; Lecendreux M; Dauvilliers Y
Rev Neurol (Paris); 2017; 173(1-2):8-18. PubMed ID: 27865546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
